BiotechTube
Home/Aion Medicines/Gary Elliott
GE

Gary Elliott

CMC

Aion Medicines

Therapeutic Areas

Metabolic DiseaseAddiction Medicine

Aion Medicines Pipeline

DrugIndicationPhase
AM-710Type II Diabetes, ObesityPreclinical
AM-510Opioid Use DisorderDiscovery

Leadership Team at Aion Medicines

AY
Alborz Yazdi
Co-Founder and CEO
BK
Brian Kearney, PharmD
Chief Scientific and Development Officer
BE
Benson Edagwa
SVP, Head of Discovery
NM
Nick Morra
CMC
MC
Michael Crowley
CMC
View full Aion Medicines profile